Skip to content

Clinical trials

Community-Acquired Pneumonia trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Community-Acquired Pneumonia Country / region: Russia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20091
20151
20162
20171
20204
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Forest Laboratories2
Nabriva Therapeutics AG2
Bayer1
Biotest1
I.M. Sechenov First Moscow State Medical University1
Materia Medica Holding1
Melinta Therapeutics, Inc.1
Paratek Pharmaceuticals Inc1
Pfizer1
R-Pharm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Community-Acquired Pneumonia15
Pneumonia5
Pneumonia, Bacterial4
Haemophilus Infections2
Bronchitis1
COVID-191
Communicable Diseases1
Coronavirus Infections1
Healthcare-Associated Pneumonia1
Pulmonary Disease, Chronic Obstructive1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.